⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONCO News
Onconetix, Inc. Common Stock
OncoHost Named Gold Winner in 2025 Merit Awards for Healthcare - Technology Solution of the Year
prnewswire.com
ONCO
Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671
globenewswire.com
ONCO
OncoPrecision Announces Oral Presentation of ONC001, a First-in-Class CD64-Targeting ADC for Monocytic Leukemia, at the 67th ASH Annual Meeting USA - English USA - Français USA - Deutsch USA - español USA - English
prnewswire.com
ONCO
Lors de la 67e réunion annuelle de l'ASH, OncoPrecision a annoncé la présentation orale de ONC001, un conjugué anticorps-médicament ciblant le récepteur CD64, premier de sa catégorie, pour la leucémie monocytaire. USA - Français USA - English USA -
prnewswire.com
ONCO
OncoPrecision Announces Oral Presentation of ONC001, a First-in-Class CD64-Targeting ADC for Monocytic Leukemia, at the 67th ASH Annual Meeting USA - English USA - Deutsch USA - Français USA - español USA - English
prnewswire.com
ONCO
OncoPrecision gibt an, dass es auf der 67. ASH-Jahrestagung eine mündliche Präsentation zu ONC001, einem erstklassigen CD64-gerichteten ADC für monozytäre Leukämie, durchführen wird USA - Deutsch USA - Français USA - español USA - English USA - English
prnewswire.com
ONCO
Oncolytic Virus CDMO Services Market to Reach USD 1734.41 Million, at 15.25% CAGR by 2035
globenewswire.com
CALI
KVIR
ONCO
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
prnewswire.com
GTBP
IMAB
ENGN
ONCO
NBTX
GTBP
IMAB
ENGN
ONCO
NBTX
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement
globenewswire.com
ONCO
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
globenewswire.com
ONCO